About Biolidics
Biolidics is a company based in Singapore (Singapore) founded in 2009. It operates as a HealthTech. The company has 7 employees as of December 31, 2024. Biolidics offers products and services including ClearCell FX1 System. Biolidics operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Singapore, Singapore
- Employees 7 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Embracing Future Holdings Limited
-
Annual Revenue
$575.03 K (USD)183.03as on Dec 31, 2024
-
Net Profit
-$2.52 M (USD)-38.02as on Dec 31, 2024
-
EBITDA
-$2.33 M (USD)-130.31as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biolidics
Biolidics is a publicly listed company on the SGX with ticker symbol 8YY in Singapore, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biolidics
Biolidics offers a comprehensive portfolio of products and services, including ClearCell FX1 System.
Automated system for cancer cell separation from blood.
People of Biolidics
Unlock access to complete
Unlock access to complete
Funding Insights of Biolidics
Detailed funding history for Biolidics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biolidics
Investment portfolio details for Biolidics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biolidics
Detailed financials for Biolidics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biolidics Comparisons
Peer comparison for Biolidics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biolidics
Biolidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
Detailed competitors of Biolidics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biolidics
Complete news archive for Biolidics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolidics
Biolidics was founded in 2009.
Biolidics is headquartered in Singapore, Singapore.
As of Dec 31, 2024, the latest employee count at Biolidics is 7.
Annual revenue of Biolidics is $575.03K as on Dec 31, 2024.
Biolidics Limited is focused on developing innovative diagnostic solutions to reduce healthcare costs and improve clinical outcomes. A portfolio of medical devices, including the ClearCell FX1 System for cancer cell separation, is offered. Additionally, technology-enabled lifestyle businesses such as Multi-Channel Networks, live streaming e-commerce platforms, and Esports-related ventures are being explored for long-term growth and diversification.
Biolidics's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
Biolidics offers ClearCell FX1 System.
Yes, Biolidics is publicly traded on SGX under the ticker symbol 8YY.
The ticker symbol of Biolidics is 8YY on SGX.